Â¥
7.12
Sep 25
New Key Statistics Module, Z-Score and F-Score
SZSE:002644 Key Ratios
Market Cap ¥ M | 3,635.88 |
Enterprise Value ¥ M | 3,227.55 |
P/E(ttm) | 79.11 |
PE Ratio without NRI | 50.50 |
Forward PE Ratio | -- |
Price/Book | 2.06 |
Price/Sales | 3.50 |
Price/Free Cash Flow | 54.76 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.21 |
Revenue (TTM) ¥ M | 1,036.00 |
EPS (TTM) ¥ | 0.09 |
Beneish M-Score | -2.8 |
10-y EBITDA Growth Rate % | 10.20 |
5-y EBITDA Growth Rate % | 4.00 |
y-y EBITDA Growth Rate % | -61.80 |
EV-to-EBIT | 59.37 |
EV-to-EBITDA | 59.37 |
PEG | 12.63 |
Shares Outstanding M | 510.66 |
Net Margin (%) | 4.39 |
Operating Margin % | 8.83 |
Pre-tax Margin (%) | 5.13 |
Quick Ratio | 1.90 |
Current Ratio | 2.90 |
ROA % (ttm) | 1.79 |
ROE % (ttm) | 2.59 |
ROIC % (ttm) | 4.57 |
Dividend Yield % | 0.42 |
Altman Z-Score | 4.14 |
SZSE:002644 Number of Guru Trades
SZSE:002644 Volume of Guru Trades
Gurus Latest Trades with SZSE:002644
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002644 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lanzhou Foci Pharmaceutical Co Ltd Insider Transactions
No Available Data